Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Thrombosis Research

• Publication date

  2010-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.thromres.2010.05.023PMID 20637495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A multicolor flow cytometric assay for measurement of platelet-derived microparticles.

  2010cited by this paper
• Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction.

  2009cited by this paper
• A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

  2009cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Structure of fibrin: impact on clot stability

  2007cited by this paper
• Human platelets synthesize and express functional tissue factor.

  2007cited by this paper
• Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes.

  2007cited by this paper
• Sources of tissue factor.

  2006cited by this paper
• Thrombin generation, a function test of the haemostaticthrombotic system

  2006cited by this paper
• Anticipatory Cognitive Stress Appraisal and the Acute Procoagulant Stress Response in Men

  2006cited by this paper
• Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets

  2006cited by this paper
• Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease

  2006cited by this paper
• Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus.

  2005cited by this paper
• Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials

  2005cited by this paper
• Pravastatin reduces fibrinogen receptor gpIIIa on platelet‐derived microparticles in patients with type 2 diabetes

  2005cited by this paper
• Platelets: Physiology and Biochemistry

  2005cited by this paper
• Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria

  2005cited by this paper
• Tissue factor activity in whole blood.

  2005cited by this paper
• Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• New nonlipid effects of statins and their clinical relevance in cardiovascular disease

  2004cited by this paper
• Statins and Blood Coagulation

  2004influential reference
• Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation

  2004cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin

  2003cited by this paper
• Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion

  2003cited by this paper
• Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease.

  2002cited by this paper
• Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.

  2000cited by this paper
• Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

  2000cited by this paper
• Platelet-derived microparticles associate with fibrin during thrombosis.

  1996cited by this paper
• Influence of cholesterol-lowering on plasma membrane lipids and function.

  1996cited by this paper
• Altered properties of the fibrin gel structure in patients with IDDM

  1996cited by this paper
• Gemfibrozil Reduces Thrombin Generation in Patients with Combined Hyperlipidaemia, without Influencing Plasma Fibrinogen, Fibrin Gel Structure or Coagulation Factor VII

  1996cited by this paper
• Platelet cytosolic Ca2+ and membrane dynamics in patients with primary hypercholesterolemia. Effects of pravastatin.

  1995cited by this paper
• Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia.

  1995cited by this paper
• Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus.

  1995cited by this paper
• Fibrinogen Plasma Levels as a Marker of Thrombin Activation in Diabetes

  1994cited by this paper
• Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation.

  1994influential reference
• Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes

  1992cited by this paper
• Native fibrin gel networks observed by 3D microscopy, permeation and turbidity.

  1989cited by this paper
• Fibrin gel structure and clotting time.

  1982cited by this paper

• Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities

  2024cites this paper
• Extracellular vesicles from patients with coronary artery disease (CAD) demonstrate enhanced pro-coagulatory activity

  2023cites this paper
• Statin Treatment on Cardiovascular Risk After Retinal Artery Occlusion: A Historical Cohort Study

  2023cites this paper
• Shear stimulated red blood cell microparticles: Effect on clot structure, flow and fibrinolysis

  2023cites this paper
• Atorvastatin-mediated inhibition of prenylation of Rab27b and Rap1a in platelets attenuates their prothrombotic capacity and modulates clot structure

  2023cites this paper
• Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence.

  2023cites this paper
• Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets

  2022cites this paper
• Relationship between lipoproteins, thrombosis, and atrial fibrillation

  2021cites this paper
• Exploring pleiotropic effects of lipid modifiers on coagulation and hemostasis with genetics

  2021cites this paper
• Extracellular Vesicles in Comorbidities Associated with Ischaemic Heart Disease: Focus on Sex, an Overlooked Factor

  2021cites this paper
• Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology

  2020cites this paper
• The potential of Atorvastatin for chronic lung diseases therapy

  2020cites this paper
• Influence of Statins on Circulating Inflammatory Cytokines in Patients with Abnormal Glucose Homeostasis: A Meta-Analysis of Data From Randomized Controlled Trials.

  2020cites this paper
• Microparticles and cardiovascular diseases

  2019cites this paper
• Effect of high dose versus low dose of atorvastatin therapy on inflammation and coagulation factors in type 2 diabetic patients; a randomized clinical trial study

  2019cites this paper
• Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study

  2019cites this paper
• Biomarkers in endotoxemia with a special interest in citrullinated histone H3

  2018cites this paper
• Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care

  2018cites this paper
• Comparison of Visual Pathology Secondary to the Light of Polymerization. Bibliographic Review of the 5 Main Types of Light in the Market

  2018cites this paper
• Chapter 9 Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2018cites this paper
• Glycated LDL-C and glycated HDL-C in association with adiposity, blood and atherogenicity indices in metabolic syndrome patients with and without prediabetes

  2018cites this paper
• Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million Patients

  2018cites this paper
• Effect of atorvastatin on testosterone levels.

  2018cites this paper
• Extracellular vesicles in obesity and diabetes mellitus.

  2017cites this paper
• The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles

  2017cites this paper
• Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse

  2017cites this paper
• Mikrocząsteczki błon komórkowych — nowy gracz na scenie chorób układu sercowo-naczyniowego

  2016cites this paper
• Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.

  2016cites this paper
• Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1

  2016cites this paper
• High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes.

  2016cites this paper
• The association of hematologic inflammatory markers with atherogenic index in type 2 diabetic retinopathy patients

  2016cites this paper
• Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease.

  2016cites this paper
• Flowcytometric assessment of platelet microparticles CD41 and CD62P in E/BETA-thalassemia patients in public hospitals in Selangor, Malaysia

  2016cites this paper
• The association of hematologic inflammatory markers with atherogenic index in type 2 diabetic retinopathy patients

  2016cites this paper
• Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis

  2016cites this paper
• Microparticles in Atherosclerosis: Biomarkers of Disease

  2015cites this paper
• Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease

  2015cites this paper
• Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots

  2015cites this paper
• Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2015cites this paper
• Effects of lipid-lowering treatment on platelet function and hemostatic mechanisms in diabetic patients : influence of chronic kidney disease and inflammatory parameters

  2014cites this paper
• Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.

  2014cites this paper
• Risks and Benefits of Statin Use in Young People with Type 1 Diabetes

  2014cites this paper
• Microvesicles and diabetic complications — novel mediators, potential biomarkers and therapeutic targets

  2014cites this paper
• Prothrombotic Changes in Diabetes Mellitus

  2013cites this paper
• Statins Therapy: Effects on Plasma Fibrinogen Levels and Fibrinolysis

  2013cites this paper
• Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.

  2013cites this paper
• “ Discovery is to see what everybody has seen and think what nobody has thought

  2013cites this paper
• Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells

  2013cites this paper
• Predictors of and survival after incident stroke in type 1 diabetes

  2013cites this paper
• Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes

  2013cites this paper
• Mechanisms of fibrin polymerization and clinical implications.

  2013cites this paper
• Enhanced platelet activity and thrombosis in a murine model of type I diabetes are partially insulin‐like growth factor 1‐dependent and phosphoinositide 3‐kinase‐dependent

  2013cites this paper
• Thrombin generation in acute cardioembolic and non-cardioembolic ischemic stroke

  2013cites this paper
• Statin therapy and levels of hemostatic factors in a healthy population: the Multi‐Ethnic Study of Atherosclerosis

  2013cites this paper
• Fibrin(ogen) and thrombotic disease

  2013cites this paper
• Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?

  2012cites this paper
• Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes

  2012cites this paper
• Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders.

  2012cites this paper
• Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials

  2012cites this paper
• Simultaneous Determination of Atorvastatin and Aspirin in Human Plasma by LC–MS/MS: Its Pharmacokinetic Application

  2012cites this paper
• All-trans-Retinoic Acid Ameliorated High Fat Diet-Induced Atherosclerosis in Rabbits by Inhibiting Platelet Activation and Inflammation

  2012cites this paper
• High-Dose Aspirin Is Required to Influence Plasma Fibrin Network Structure in Patients With Type 1 Diabetes

  2012cites this paper
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012cites this paper
• Anti-Inflammatory Therapy in Type 1 Diabetes

  2012cites this paper
• Studies of haemostasis in acute coronary syndromes and diabetes mellitus

  2011cites this paper
• Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.

  2011cites this paper
• Associations between cardiovascular risk factors, hyper- and hypocoagulability

  2011cites this paper
• Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease

  2011cites this paper
• Atorvastatin and its collateral effects on microparticles

  2011cites this paper
• Hemostatic disturbances in acute ischemic stroke

  2011cites this paper
• Clinical Ophthalmology Dovepress Dovepress the Association of Hematologic Inflammatory Markers with Atherogenic Index in Type 2 Diabetic Retinopathy Patients

  year unknowncites this paper